nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2D6—Alzheimer's disease	0.363	1	CbGaD
Flecainide—CYP2D6—Rivastigmine—Alzheimer's disease	0.122	0.314	CbGbCtD
Flecainide—CYP2C9—Donepezil—Alzheimer's disease	0.106	0.274	CbGbCtD
Flecainide—CYP2D6—Donepezil—Alzheimer's disease	0.0973	0.251	CbGbCtD
Flecainide—CYP2D6—Galantamine—Alzheimer's disease	0.0627	0.162	CbGbCtD
Flecainide—Mefloquine—ACHE—Alzheimer's disease	0.00358	0.523	CrCbGaD
Flecainide—Mefloquine—BCHE—Alzheimer's disease	0.00211	0.308	CrCbGaD
Flecainide—Mefloquine—CYP2D6—Alzheimer's disease	0.00116	0.169	CrCbGaD
Flecainide—SCN4A—L1CAM interactions—DPYSL2—Alzheimer's disease	0.000632	0.0329	CbGpPWpGaD
Flecainide—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000502	0.00225	CcSEcCtD
Flecainide—Dysuria—Rivastigmine—Alzheimer's disease	0.0005	0.00224	CcSEcCtD
Flecainide—Hyperglycaemia—Memantine—Alzheimer's disease	0.000493	0.00221	CcSEcCtD
Flecainide—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000492	0.00221	CcSEcCtD
Flecainide—Bradycardia—Donepezil—Alzheimer's disease	0.00049	0.0022	CcSEcCtD
Flecainide—Pneumonia—Memantine—Alzheimer's disease	0.00049	0.0022	CcSEcCtD
Flecainide—Malaise—Galantamine—Alzheimer's disease	0.000488	0.00219	CcSEcCtD
Flecainide—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000488	0.00219	CcSEcCtD
Flecainide—Vertigo—Galantamine—Alzheimer's disease	0.000486	0.00218	CcSEcCtD
Flecainide—Syncope—Galantamine—Alzheimer's disease	0.000485	0.00218	CcSEcCtD
Flecainide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000482	0.00216	CcSEcCtD
Flecainide—Pneumonia—Rivastigmine—Alzheimer's disease	0.000479	0.00215	CcSEcCtD
Flecainide—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000479	0.00215	CcSEcCtD
Flecainide—Hallucination—Donepezil—Alzheimer's disease	0.000479	0.00215	CcSEcCtD
Flecainide—Renal failure—Memantine—Alzheimer's disease	0.000479	0.00215	CcSEcCtD
Flecainide—Palpitations—Galantamine—Alzheimer's disease	0.000478	0.00214	CcSEcCtD
Flecainide—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000478	0.00214	CcSEcCtD
Flecainide—Loss of consciousness—Galantamine—Alzheimer's disease	0.000475	0.00213	CcSEcCtD
Flecainide—Cough—Galantamine—Alzheimer's disease	0.000472	0.00212	CcSEcCtD
Flecainide—Convulsion—Galantamine—Alzheimer's disease	0.000469	0.0021	CcSEcCtD
Flecainide—Renal failure—Rivastigmine—Alzheimer's disease	0.000468	0.0021	CcSEcCtD
Flecainide—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000467	0.00209	CcSEcCtD
Flecainide—Hypertension—Galantamine—Alzheimer's disease	0.000467	0.00209	CcSEcCtD
Flecainide—Haematuria—Memantine—Alzheimer's disease	0.000464	0.00208	CcSEcCtD
Flecainide—Visual impairment—Donepezil—Alzheimer's disease	0.000464	0.00208	CcSEcCtD
Flecainide—Arthralgia—Galantamine—Alzheimer's disease	0.000461	0.00207	CcSEcCtD
Flecainide—Chest pain—Galantamine—Alzheimer's disease	0.000461	0.00207	CcSEcCtD
Flecainide—Myalgia—Galantamine—Alzheimer's disease	0.000461	0.00207	CcSEcCtD
Flecainide—Anxiety—Galantamine—Alzheimer's disease	0.000459	0.00206	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000457	0.00205	CcSEcCtD
Flecainide—Discomfort—Galantamine—Alzheimer's disease	0.000455	0.00204	CcSEcCtD
Flecainide—Agranulocytosis—Memantine—Alzheimer's disease	0.000455	0.00204	CcSEcCtD
Flecainide—Haematuria—Rivastigmine—Alzheimer's disease	0.000454	0.00204	CcSEcCtD
Flecainide—Dry mouth—Galantamine—Alzheimer's disease	0.00045	0.00202	CcSEcCtD
Flecainide—Tinnitus—Donepezil—Alzheimer's disease	0.000449	0.00201	CcSEcCtD
Flecainide—Confusional state—Galantamine—Alzheimer's disease	0.000445	0.002	CcSEcCtD
Flecainide—Bradycardia—Memantine—Alzheimer's disease	0.000445	0.002	CcSEcCtD
Flecainide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000436	0.00195	CcSEcCtD
Flecainide—Hypoaesthesia—Memantine—Alzheimer's disease	0.000435	0.00195	CcSEcCtD
Flecainide—Hallucination—Memantine—Alzheimer's disease	0.000435	0.00195	CcSEcCtD
Flecainide—Shock—Galantamine—Alzheimer's disease	0.000434	0.00195	CcSEcCtD
Flecainide—Nervous system disorder—Galantamine—Alzheimer's disease	0.000433	0.00194	CcSEcCtD
Flecainide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000432	0.00194	CcSEcCtD
Flecainide—Tachycardia—Galantamine—Alzheimer's disease	0.000431	0.00193	CcSEcCtD
Flecainide—Skin disorder—Galantamine—Alzheimer's disease	0.000429	0.00192	CcSEcCtD
Flecainide—SCN5A—L1CAM interactions—DPYSL2—Alzheimer's disease	0.000428	0.0223	CbGpPWpGaD
Flecainide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000427	0.00191	CcSEcCtD
Flecainide—Hallucination—Rivastigmine—Alzheimer's disease	0.000426	0.00191	CcSEcCtD
Flecainide—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000426	0.00191	CcSEcCtD
Flecainide—Alopecia—Donepezil—Alzheimer's disease	0.000426	0.00191	CcSEcCtD
Flecainide—Visual impairment—Memantine—Alzheimer's disease	0.000421	0.00189	CcSEcCtD
Flecainide—Anorexia—Galantamine—Alzheimer's disease	0.000421	0.00189	CcSEcCtD
Flecainide—Flatulence—Donepezil—Alzheimer's disease	0.000413	0.00185	CcSEcCtD
Flecainide—Hypotension—Galantamine—Alzheimer's disease	0.000413	0.00185	CcSEcCtD
Flecainide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000412	0.00185	CcSEcCtD
Flecainide—Tension—Donepezil—Alzheimer's disease	0.000411	0.00184	CcSEcCtD
Flecainide—Dysgeusia—Donepezil—Alzheimer's disease	0.000411	0.00184	CcSEcCtD
Flecainide—Eye disorder—Memantine—Alzheimer's disease	0.000409	0.00183	CcSEcCtD
Flecainide—Tinnitus—Memantine—Alzheimer's disease	0.000408	0.00183	CcSEcCtD
Flecainide—Nervousness—Donepezil—Alzheimer's disease	0.000407	0.00183	CcSEcCtD
Flecainide—Flushing—Memantine—Alzheimer's disease	0.000406	0.00182	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000402	0.0018	CcSEcCtD
Flecainide—Eye disorder—Rivastigmine—Alzheimer's disease	0.0004	0.00179	CcSEcCtD
Flecainide—Insomnia—Galantamine—Alzheimer's disease	0.000399	0.00179	CcSEcCtD
Flecainide—Tinnitus—Rivastigmine—Alzheimer's disease	0.000399	0.00179	CcSEcCtD
Flecainide—Flushing—Rivastigmine—Alzheimer's disease	0.000397	0.00178	CcSEcCtD
Flecainide—Paraesthesia—Galantamine—Alzheimer's disease	0.000396	0.00178	CcSEcCtD
Flecainide—Vision blurred—Donepezil—Alzheimer's disease	0.000395	0.00177	CcSEcCtD
Flecainide—Immune system disorder—Memantine—Alzheimer's disease	0.000395	0.00177	CcSEcCtD
Flecainide—Tremor—Donepezil—Alzheimer's disease	0.000393	0.00176	CcSEcCtD
Flecainide—Somnolence—Galantamine—Alzheimer's disease	0.000393	0.00176	CcSEcCtD
Flecainide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000389	0.00174	CcSEcCtD
Flecainide—Dyspepsia—Galantamine—Alzheimer's disease	0.000389	0.00174	CcSEcCtD
Flecainide—Alopecia—Memantine—Alzheimer's disease	0.000386	0.00173	CcSEcCtD
Flecainide—Decreased appetite—Galantamine—Alzheimer's disease	0.000384	0.00172	CcSEcCtD
Flecainide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000381	0.00171	CcSEcCtD
Flecainide—Fatigue—Galantamine—Alzheimer's disease	0.000381	0.00171	CcSEcCtD
Flecainide—Malaise—Donepezil—Alzheimer's disease	0.000378	0.0017	CcSEcCtD
Flecainide—Alopecia—Rivastigmine—Alzheimer's disease	0.000378	0.0017	CcSEcCtD
Flecainide—Constipation—Galantamine—Alzheimer's disease	0.000378	0.00169	CcSEcCtD
Flecainide—Vertigo—Donepezil—Alzheimer's disease	0.000377	0.00169	CcSEcCtD
Flecainide—Syncope—Donepezil—Alzheimer's disease	0.000376	0.00169	CcSEcCtD
Flecainide—Flatulence—Memantine—Alzheimer's disease	0.000375	0.00168	CcSEcCtD
Flecainide—Tension—Memantine—Alzheimer's disease	0.000374	0.00168	CcSEcCtD
Flecainide—Dysgeusia—Memantine—Alzheimer's disease	0.000373	0.00167	CcSEcCtD
Flecainide—Nervousness—Memantine—Alzheimer's disease	0.00037	0.00166	CcSEcCtD
Flecainide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000369	0.00165	CcSEcCtD
Flecainide—Flatulence—Rivastigmine—Alzheimer's disease	0.000367	0.00165	CcSEcCtD
Flecainide—Cough—Donepezil—Alzheimer's disease	0.000366	0.00164	CcSEcCtD
Flecainide—Tension—Rivastigmine—Alzheimer's disease	0.000365	0.00164	CcSEcCtD
Flecainide—CYP2C9—CYP2E1 reactions—CYP2D6—Alzheimer's disease	0.000365	0.019	CbGpPWpGaD
Flecainide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000365	0.00164	CcSEcCtD
Flecainide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000364	0.00163	CcSEcCtD
Flecainide—Convulsion—Donepezil—Alzheimer's disease	0.000363	0.00163	CcSEcCtD
Flecainide—Hypertension—Donepezil—Alzheimer's disease	0.000362	0.00162	CcSEcCtD
Flecainide—Nervousness—Rivastigmine—Alzheimer's disease	0.000362	0.00162	CcSEcCtD
Flecainide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000361	0.00162	CcSEcCtD
Flecainide—Vision blurred—Memantine—Alzheimer's disease	0.000359	0.00161	CcSEcCtD
Flecainide—Chest pain—Donepezil—Alzheimer's disease	0.000357	0.0016	CcSEcCtD
Flecainide—Arthralgia—Donepezil—Alzheimer's disease	0.000357	0.0016	CcSEcCtD
Flecainide—Myalgia—Donepezil—Alzheimer's disease	0.000357	0.0016	CcSEcCtD
Flecainide—Tremor—Memantine—Alzheimer's disease	0.000357	0.0016	CcSEcCtD
Flecainide—Anxiety—Donepezil—Alzheimer's disease	0.000356	0.0016	CcSEcCtD
Flecainide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000353	0.00158	CcSEcCtD
Flecainide—Discomfort—Donepezil—Alzheimer's disease	0.000353	0.00158	CcSEcCtD
Flecainide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000351	0.00157	CcSEcCtD
Flecainide—Dry mouth—Donepezil—Alzheimer's disease	0.000349	0.00157	CcSEcCtD
Flecainide—Abdominal pain—Galantamine—Alzheimer's disease	0.000349	0.00157	CcSEcCtD
Flecainide—Body temperature increased—Galantamine—Alzheimer's disease	0.000349	0.00157	CcSEcCtD
Flecainide—Tremor—Rivastigmine—Alzheimer's disease	0.000349	0.00156	CcSEcCtD
Flecainide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000346	0.00155	CcSEcCtD
Flecainide—Confusional state—Donepezil—Alzheimer's disease	0.000345	0.00155	CcSEcCtD
Flecainide—Malaise—Memantine—Alzheimer's disease	0.000343	0.00154	CcSEcCtD
Flecainide—Oedema—Donepezil—Alzheimer's disease	0.000342	0.00153	CcSEcCtD
Flecainide—Vertigo—Memantine—Alzheimer's disease	0.000342	0.00153	CcSEcCtD
Flecainide—Syncope—Memantine—Alzheimer's disease	0.000341	0.00153	CcSEcCtD
Flecainide—Leukopenia—Memantine—Alzheimer's disease	0.000341	0.00153	CcSEcCtD
Flecainide—CYP2C9—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000339	0.0176	CbGpPWpGaD
Flecainide—Shock—Donepezil—Alzheimer's disease	0.000337	0.00151	CcSEcCtD
Flecainide—Palpitations—Memantine—Alzheimer's disease	0.000336	0.00151	CcSEcCtD
Flecainide—Malaise—Rivastigmine—Alzheimer's disease	0.000336	0.00151	CcSEcCtD
Flecainide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000336	0.0015	CcSEcCtD
Flecainide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000335	0.0015	CcSEcCtD
Flecainide—Vertigo—Rivastigmine—Alzheimer's disease	0.000335	0.0015	CcSEcCtD
Flecainide—Loss of consciousness—Memantine—Alzheimer's disease	0.000335	0.0015	CcSEcCtD
Flecainide—Syncope—Rivastigmine—Alzheimer's disease	0.000334	0.0015	CcSEcCtD
Flecainide—Cough—Memantine—Alzheimer's disease	0.000332	0.00149	CcSEcCtD
Flecainide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000331	0.00148	CcSEcCtD
Flecainide—Convulsion—Memantine—Alzheimer's disease	0.00033	0.00148	CcSEcCtD
Flecainide—CYP2D6—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.000329	0.0172	CbGpPWpGaD
Flecainide—Palpitations—Rivastigmine—Alzheimer's disease	0.000329	0.00148	CcSEcCtD
Flecainide—Hypertension—Memantine—Alzheimer's disease	0.000329	0.00147	CcSEcCtD
Flecainide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000327	0.00147	CcSEcCtD
Flecainide—Anorexia—Donepezil—Alzheimer's disease	0.000326	0.00146	CcSEcCtD
Flecainide—Cough—Rivastigmine—Alzheimer's disease	0.000325	0.00146	CcSEcCtD
Flecainide—Chest pain—Memantine—Alzheimer's disease	0.000324	0.00145	CcSEcCtD
Flecainide—Arthralgia—Memantine—Alzheimer's disease	0.000324	0.00145	CcSEcCtD
Flecainide—Myalgia—Memantine—Alzheimer's disease	0.000324	0.00145	CcSEcCtD
Flecainide—Anxiety—Memantine—Alzheimer's disease	0.000323	0.00145	CcSEcCtD
Flecainide—Convulsion—Rivastigmine—Alzheimer's disease	0.000323	0.00145	CcSEcCtD
Flecainide—Hypertension—Rivastigmine—Alzheimer's disease	0.000322	0.00144	CcSEcCtD
Flecainide—Discomfort—Memantine—Alzheimer's disease	0.00032	0.00144	CcSEcCtD
Flecainide—Hypotension—Donepezil—Alzheimer's disease	0.00032	0.00143	CcSEcCtD
Flecainide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000317	0.00142	CcSEcCtD
Flecainide—Chest pain—Rivastigmine—Alzheimer's disease	0.000317	0.00142	CcSEcCtD
Flecainide—Myalgia—Rivastigmine—Alzheimer's disease	0.000317	0.00142	CcSEcCtD
Flecainide—Dry mouth—Memantine—Alzheimer's disease	0.000317	0.00142	CcSEcCtD
Flecainide—Asthenia—Galantamine—Alzheimer's disease	0.000317	0.00142	CcSEcCtD
Flecainide—Anxiety—Rivastigmine—Alzheimer's disease	0.000316	0.00142	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000315	0.00141	CcSEcCtD
Flecainide—Confusional state—Memantine—Alzheimer's disease	0.000313	0.0014	CcSEcCtD
Flecainide—Discomfort—Rivastigmine—Alzheimer's disease	0.000313	0.0014	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000312	0.0014	CcSEcCtD
Flecainide—Oedema—Memantine—Alzheimer's disease	0.000311	0.00139	CcSEcCtD
Flecainide—Dry mouth—Rivastigmine—Alzheimer's disease	0.00031	0.00139	CcSEcCtD
Flecainide—Insomnia—Donepezil—Alzheimer's disease	0.000309	0.00139	CcSEcCtD
Flecainide—Paraesthesia—Donepezil—Alzheimer's disease	0.000307	0.00138	CcSEcCtD
Flecainide—Confusional state—Rivastigmine—Alzheimer's disease	0.000306	0.00137	CcSEcCtD
Flecainide—Shock—Memantine—Alzheimer's disease	0.000306	0.00137	CcSEcCtD
Flecainide—Dyspnoea—Donepezil—Alzheimer's disease	0.000305	0.00137	CcSEcCtD
Flecainide—Nervous system disorder—Memantine—Alzheimer's disease	0.000305	0.00137	CcSEcCtD
Flecainide—Somnolence—Donepezil—Alzheimer's disease	0.000304	0.00136	CcSEcCtD
Flecainide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000304	0.00136	CcSEcCtD
Flecainide—Oedema—Rivastigmine—Alzheimer's disease	0.000304	0.00136	CcSEcCtD
Flecainide—Tachycardia—Memantine—Alzheimer's disease	0.000303	0.00136	CcSEcCtD
Flecainide—Diarrhoea—Galantamine—Alzheimer's disease	0.000302	0.00135	CcSEcCtD
Flecainide—Skin disorder—Memantine—Alzheimer's disease	0.000302	0.00135	CcSEcCtD
Flecainide—Dyspepsia—Donepezil—Alzheimer's disease	0.000301	0.00135	CcSEcCtD
Flecainide—Hyperhidrosis—Memantine—Alzheimer's disease	0.0003	0.00135	CcSEcCtD
Flecainide—Shock—Rivastigmine—Alzheimer's disease	0.000299	0.00134	CcSEcCtD
Flecainide—SCN4A—Axon guidance—TREM2—Alzheimer's disease	0.000299	0.0156	CbGpPWpGaD
Flecainide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000298	0.00134	CcSEcCtD
Flecainide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000298	0.00133	CcSEcCtD
Flecainide—Decreased appetite—Donepezil—Alzheimer's disease	0.000297	0.00133	CcSEcCtD
Flecainide—Tachycardia—Rivastigmine—Alzheimer's disease	0.000297	0.00133	CcSEcCtD
Flecainide—Anorexia—Memantine—Alzheimer's disease	0.000296	0.00133	CcSEcCtD
Flecainide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000295	0.00132	CcSEcCtD
Flecainide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000295	0.00132	CcSEcCtD
Flecainide—Fatigue—Donepezil—Alzheimer's disease	0.000295	0.00132	CcSEcCtD
Flecainide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000294	0.00132	CcSEcCtD
Flecainide—Pain—Donepezil—Alzheimer's disease	0.000293	0.00131	CcSEcCtD
Flecainide—Constipation—Donepezil—Alzheimer's disease	0.000293	0.00131	CcSEcCtD
Flecainide—Dizziness—Galantamine—Alzheimer's disease	0.000292	0.00131	CcSEcCtD
Flecainide—Hypotension—Memantine—Alzheimer's disease	0.00029	0.0013	CcSEcCtD
Flecainide—Anorexia—Rivastigmine—Alzheimer's disease	0.00029	0.0013	CcSEcCtD
Flecainide—SCN4A—L1CAM interactions—DLG4—Alzheimer's disease	0.000285	0.0149	CbGpPWpGaD
Flecainide—Hypotension—Rivastigmine—Alzheimer's disease	0.000284	0.00127	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000283	0.00127	CcSEcCtD
Flecainide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000282	0.00126	CcSEcCtD
Flecainide—Insomnia—Memantine—Alzheimer's disease	0.000281	0.00126	CcSEcCtD
Flecainide—Vomiting—Galantamine—Alzheimer's disease	0.000281	0.00126	CcSEcCtD
Flecainide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00028	0.00125	CcSEcCtD
Flecainide—Paraesthesia—Memantine—Alzheimer's disease	0.000279	0.00125	CcSEcCtD
Flecainide—Rash—Galantamine—Alzheimer's disease	0.000278	0.00125	CcSEcCtD
Flecainide—Dermatitis—Galantamine—Alzheimer's disease	0.000278	0.00125	CcSEcCtD
Flecainide—Dyspnoea—Memantine—Alzheimer's disease	0.000277	0.00124	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000277	0.00124	CcSEcCtD
Flecainide—Headache—Galantamine—Alzheimer's disease	0.000277	0.00124	CcSEcCtD
Flecainide—Somnolence—Memantine—Alzheimer's disease	0.000276	0.00124	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000275	0.0143	CbGpPWpGaD
Flecainide—Insomnia—Rivastigmine—Alzheimer's disease	0.000275	0.00123	CcSEcCtD
Flecainide—Dyspepsia—Memantine—Alzheimer's disease	0.000273	0.00123	CcSEcCtD
Flecainide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000273	0.00122	CcSEcCtD
Flecainide—Urticaria—Donepezil—Alzheimer's disease	0.000272	0.00122	CcSEcCtD
Flecainide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000271	0.00122	CcSEcCtD
Flecainide—Abdominal pain—Donepezil—Alzheimer's disease	0.000271	0.00121	CcSEcCtD
Flecainide—Body temperature increased—Donepezil—Alzheimer's disease	0.000271	0.00121	CcSEcCtD
Flecainide—Somnolence—Rivastigmine—Alzheimer's disease	0.00027	0.00121	CcSEcCtD
Flecainide—Decreased appetite—Memantine—Alzheimer's disease	0.00027	0.00121	CcSEcCtD
Flecainide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000268	0.0012	CcSEcCtD
Flecainide—Fatigue—Memantine—Alzheimer's disease	0.000268	0.0012	CcSEcCtD
Flecainide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000268	0.0012	CcSEcCtD
Flecainide—Constipation—Memantine—Alzheimer's disease	0.000266	0.00119	CcSEcCtD
Flecainide—Pain—Memantine—Alzheimer's disease	0.000266	0.00119	CcSEcCtD
Flecainide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000264	0.00118	CcSEcCtD
Flecainide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000262	0.00118	CcSEcCtD
Flecainide—Nausea—Galantamine—Alzheimer's disease	0.000262	0.00118	CcSEcCtD
Flecainide—Fatigue—Rivastigmine—Alzheimer's disease	0.000262	0.00118	CcSEcCtD
Flecainide—Pain—Rivastigmine—Alzheimer's disease	0.00026	0.00117	CcSEcCtD
Flecainide—Constipation—Rivastigmine—Alzheimer's disease	0.00026	0.00117	CcSEcCtD
Flecainide—Feeling abnormal—Memantine—Alzheimer's disease	0.000256	0.00115	CcSEcCtD
Flecainide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000254	0.00114	CcSEcCtD
Flecainide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00025	0.00112	CcSEcCtD
Flecainide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000249	0.00111	CcSEcCtD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—IGF2—Alzheimer's disease	0.000247	0.0129	CbGpPWpGaD
Flecainide—Urticaria—Memantine—Alzheimer's disease	0.000247	0.00111	CcSEcCtD
Flecainide—Abdominal pain—Memantine—Alzheimer's disease	0.000246	0.0011	CcSEcCtD
Flecainide—Body temperature increased—Memantine—Alzheimer's disease	0.000246	0.0011	CcSEcCtD
Flecainide—Asthenia—Donepezil—Alzheimer's disease	0.000246	0.0011	CcSEcCtD
Flecainide—Pruritus—Donepezil—Alzheimer's disease	0.000242	0.00109	CcSEcCtD
Flecainide—Urticaria—Rivastigmine—Alzheimer's disease	0.000241	0.00108	CcSEcCtD
Flecainide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00024	0.00108	CcSEcCtD
Flecainide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00024	0.00108	CcSEcCtD
Flecainide—SCN4A—Axon guidance—DPYSL2—Alzheimer's disease	0.000239	0.0124	CbGpPWpGaD
Flecainide—Diarrhoea—Donepezil—Alzheimer's disease	0.000234	0.00105	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000234	0.0122	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000234	0.0122	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—MEF2C—Alzheimer's disease	0.000227	0.0118	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000227	0.0118	CbGpPWpGaD
Flecainide—CYP2C9—Xenobiotics—CYP2D6—Alzheimer's disease	0.000226	0.0118	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—EPHA1—Alzheimer's disease	0.000226	0.0118	CbGpPWpGaD
Flecainide—Dizziness—Donepezil—Alzheimer's disease	0.000226	0.00101	CcSEcCtD
Flecainide—Asthenia—Memantine—Alzheimer's disease	0.000223	0.001	CcSEcCtD
Flecainide—Pruritus—Memantine—Alzheimer's disease	0.00022	0.000986	CcSEcCtD
Flecainide—Asthenia—Rivastigmine—Alzheimer's disease	0.000218	0.000978	CcSEcCtD
Flecainide—CYP2C9—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000218	0.0114	CbGpPWpGaD
Flecainide—Vomiting—Donepezil—Alzheimer's disease	0.000218	0.000976	CcSEcCtD
Flecainide—Rash—Donepezil—Alzheimer's disease	0.000216	0.000967	CcSEcCtD
Flecainide—Dermatitis—Donepezil—Alzheimer's disease	0.000216	0.000967	CcSEcCtD
Flecainide—Pruritus—Rivastigmine—Alzheimer's disease	0.000215	0.000964	CcSEcCtD
Flecainide—Headache—Donepezil—Alzheimer's disease	0.000214	0.000961	CcSEcCtD
Flecainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000214	0.0111	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TREM2—Alzheimer's disease	0.000213	0.0111	CbGpPWpGaD
Flecainide—Diarrhoea—Memantine—Alzheimer's disease	0.000213	0.000953	CcSEcCtD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000212	0.0111	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000211	0.011	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000209	0.0109	CbGpPWpGaD
Flecainide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000208	0.000933	CcSEcCtD
Flecainide—SCN4A—Axon guidance—CDK5—Alzheimer's disease	0.000207	0.0108	CbGpPWpGaD
Flecainide—Dizziness—Memantine—Alzheimer's disease	0.000205	0.000921	CcSEcCtD
Flecainide—Nausea—Donepezil—Alzheimer's disease	0.000203	0.000911	CcSEcCtD
Flecainide—SCN5A—Axon guidance—TREM2—Alzheimer's disease	0.000202	0.0105	CbGpPWpGaD
Flecainide—Dizziness—Rivastigmine—Alzheimer's disease	0.000201	0.000901	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000199	0.0104	CbGpPWpGaD
Flecainide—Vomiting—Memantine—Alzheimer's disease	0.000198	0.000886	CcSEcCtD
Flecainide—Rash—Memantine—Alzheimer's disease	0.000196	0.000878	CcSEcCtD
Flecainide—Dermatitis—Memantine—Alzheimer's disease	0.000196	0.000878	CcSEcCtD
Flecainide—Headache—Memantine—Alzheimer's disease	0.000195	0.000873	CcSEcCtD
Flecainide—SCN5A—L1CAM interactions—DLG4—Alzheimer's disease	0.000194	0.0101	CbGpPWpGaD
Flecainide—Vomiting—Rivastigmine—Alzheimer's disease	0.000193	0.000867	CcSEcCtD
Flecainide—Rash—Rivastigmine—Alzheimer's disease	0.000192	0.000859	CcSEcCtD
Flecainide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000191	0.000859	CcSEcCtD
Flecainide—Headache—Rivastigmine—Alzheimer's disease	0.00019	0.000854	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000187	0.00975	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.000185	0.00962	CbGpPWpGaD
Flecainide—Nausea—Memantine—Alzheimer's disease	0.000185	0.000828	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000184	0.00957	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—PSENEN—Alzheimer's disease	0.000181	0.00943	CbGpPWpGaD
Flecainide—Nausea—Rivastigmine—Alzheimer's disease	0.000181	0.00081	CcSEcCtD
Flecainide—SCN4A—Axon guidance—APH1A—Alzheimer's disease	0.000178	0.0093	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—Alzheimer's disease	0.000177	0.00923	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—NCSTN—Alzheimer's disease	0.000174	0.00905	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000173	0.00904	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000172	0.00896	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—DPYSL2—Alzheimer's disease	0.00017	0.00888	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000168	0.00876	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—GSK3B—Alzheimer's disease	0.000166	0.00866	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—INS—Alzheimer's disease	0.000164	0.00854	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—DPYSL2—Alzheimer's disease	0.000162	0.00843	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—EPHA1—Alzheimer's disease	0.000161	0.00842	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—IGF1—Alzheimer's disease	0.000159	0.00826	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—EPHA1—Alzheimer's disease	0.000153	0.008	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000153	0.00795	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000151	0.00786	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—CDK5—Alzheimer's disease	0.000148	0.0077	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—PRNP—Alzheimer's disease	0.000146	0.0076	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TREM2—Alzheimer's disease	0.000144	0.00753	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000142	0.00739	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—PSEN2—Alzheimer's disease	0.000141	0.00736	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—CDK5—Alzheimer's disease	0.00014	0.00731	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000138	0.00719	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000138	0.00719	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PSENEN—Alzheimer's disease	0.000129	0.00673	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000128	0.00669	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—APH1A—Alzheimer's disease	0.000127	0.00663	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NCSTN—Alzheimer's disease	0.000124	0.00646	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—PSENEN—Alzheimer's disease	0.000123	0.00639	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—APH1A—Alzheimer's disease	0.000121	0.0063	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—NCSTN—Alzheimer's disease	0.000118	0.00614	CbGpPWpGaD
Flecainide—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000116	0.00606	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—DPYSL2—Alzheimer's disease	0.000115	0.00602	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000111	0.00578	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—EPHA1—Alzheimer's disease	0.000109	0.00571	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—DLG4—Alzheimer's disease	0.000108	0.00562	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000106	0.00552	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—GRIN2B—Alzheimer's disease	0.000105	0.00549	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PRNP—Alzheimer's disease	0.000104	0.00542	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000103	0.00539	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000103	0.00537	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000103	0.00535	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PSEN2—Alzheimer's disease	0.000101	0.00525	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CDK5—Alzheimer's disease	0.0001	0.00522	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	9.89e-05	0.00515	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—PRNP—Alzheimer's disease	9.89e-05	0.00515	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—CALM1—Alzheimer's disease	9.71e-05	0.00506	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—APOE—Alzheimer's disease	9.68e-05	0.00504	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—PSEN2—Alzheimer's disease	9.57e-05	0.00499	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	9.56e-05	0.00498	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—ADAM10—Alzheimer's disease	9.5e-05	0.00495	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—TGFB1—Alzheimer's disease	9.5e-05	0.00495	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	9.4e-05	0.0049	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	9.28e-05	0.00484	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—IAPP—Alzheimer's disease	9.22e-05	0.0048	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP46A1—Alzheimer's disease	9.21e-05	0.0048	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	9.14e-05	0.00476	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	9.13e-05	0.00476	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP46A1—Alzheimer's disease	9.08e-05	0.00473	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	9.01e-05	0.00469	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PSENEN—Alzheimer's disease	8.75e-05	0.00456	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	8.7e-05	0.00453	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—APH1A—Alzheimer's disease	8.63e-05	0.0045	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NCSTN—Alzheimer's disease	8.4e-05	0.00438	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	8.38e-05	0.00437	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.84e-05	0.00409	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.77e-05	0.00405	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—DLG4—Alzheimer's disease	7.7e-05	0.00401	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	7.62e-05	0.00397	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—GRIN2B—Alzheimer's disease	7.52e-05	0.00392	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	7.36e-05	0.00383	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—DLG4—Alzheimer's disease	7.31e-05	0.00381	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—GRIN2B—Alzheimer's disease	7.15e-05	0.00372	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PRNP—Alzheimer's disease	7.05e-05	0.00368	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	6.95e-05	0.00362	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PSEN2—Alzheimer's disease	6.83e-05	0.00356	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ADAM10—Alzheimer's disease	6.78e-05	0.00353	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ADAM10—Alzheimer's disease	6.44e-05	0.00336	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—IAPP—Alzheimer's disease	6.25e-05	0.00326	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PPARGC1A—Alzheimer's disease	6.22e-05	0.00324	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—GSK3B—Alzheimer's disease	5.76e-05	0.003	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—CREB1—Alzheimer's disease	5.71e-05	0.00298	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—LPL—Alzheimer's disease	5.66e-05	0.00295	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MEF2C—Alzheimer's disease	5.61e-05	0.00292	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	5.5e-05	0.00286	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	5.45e-05	0.00284	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	5.26e-05	0.00274	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—DLG4—Alzheimer's disease	5.22e-05	0.00272	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	5.16e-05	0.00269	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	5.14e-05	0.00268	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—GRIN2B—Alzheimer's disease	5.1e-05	0.00266	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—LEP—Alzheimer's disease	4.74e-05	0.00247	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ADAM10—Alzheimer's disease	4.6e-05	0.0024	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NOTCH1—Alzheimer's disease	4.38e-05	0.00228	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	4.37e-05	0.00228	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	4.25e-05	0.00222	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PPARGC1A—Alzheimer's disease	4.21e-05	0.0022	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	4.17e-05	0.00217	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PPARG—Alzheimer's disease	4.13e-05	0.00215	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	4.13e-05	0.00215	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—GSK3B—Alzheimer's disease	4.11e-05	0.00214	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—CREB1—Alzheimer's disease	4.08e-05	0.00212	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—INS—Alzheimer's disease	4.05e-05	0.00211	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	4.05e-05	0.00211	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.99e-05	0.00208	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—GSK3B—Alzheimer's disease	3.9e-05	0.00203	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—CREB1—Alzheimer's disease	3.87e-05	0.00202	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—LPL—Alzheimer's disease	3.84e-05	0.002	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MEF2C—Alzheimer's disease	3.8e-05	0.00198	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	3.8e-05	0.00198	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	3.74e-05	0.00195	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—VEGFA—Alzheimer's disease	3.59e-05	0.00187	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.51e-05	0.00183	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—LEP—Alzheimer's disease	3.22e-05	0.00168	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.02e-05	0.00157	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NOTCH1—Alzheimer's disease	2.97e-05	0.00155	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PPARG—Alzheimer's disease	2.8e-05	0.00146	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—GSK3B—Alzheimer's disease	2.79e-05	0.00145	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CREB1—Alzheimer's disease	2.76e-05	0.00144	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—INS—Alzheimer's disease	2.75e-05	0.00143	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—VEGFA—Alzheimer's disease	2.56e-05	0.00133	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—IL6—Alzheimer's disease	2.48e-05	0.00129	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—VEGFA—Alzheimer's disease	2.43e-05	0.00127	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.36e-05	0.00123	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TGFB1—Alzheimer's disease	2.35e-05	0.00122	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	2.34e-05	0.00122	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TNF—Alzheimer's disease	2.19e-05	0.00114	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.18e-05	0.00114	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.01e-05	0.00105	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CA4—Alzheimer's disease	1.99e-05	0.00104	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.95e-05	0.00101	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.89e-05	0.000984	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	1.87e-05	0.000975	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.79e-05	0.000932	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	1.77e-05	0.000924	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—IL6—Alzheimer's disease	1.77e-05	0.000923	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—VEGFA—Alzheimer's disease	1.74e-05	0.000905	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.71e-05	0.00089	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	1.69e-05	0.000882	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.69e-05	0.000882	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—IL6—Alzheimer's disease	1.68e-05	0.000877	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.67e-05	0.000872	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.64e-05	0.000853	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT1—Alzheimer's disease	1.63e-05	0.000852	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.62e-05	0.000845	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TGFB1—Alzheimer's disease	1.59e-05	0.00083	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.59e-05	0.000826	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.58e-05	0.000821	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.56e-05	0.000814	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.52e-05	0.000793	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.51e-05	0.000786	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TNF—Alzheimer's disease	1.49e-05	0.000775	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.47e-05	0.000768	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.35e-05	0.000703	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—IL6—Alzheimer's disease	1.2e-05	0.000626	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.16e-05	0.000606	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT1—Alzheimer's disease	1.11e-05	0.000577	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.06e-05	0.000551	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TPI1—Alzheimer's disease	9.8e-06	0.000511	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CHAT—Alzheimer's disease	9.8e-06	0.000511	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	9.72e-06	0.000507	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	9.72e-06	0.000507	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.4e-06	0.00049	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	9.32e-06	0.000486	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.05e-06	0.000472	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	8.97e-06	0.000467	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.87e-06	0.000462	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.79e-06	0.000458	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—A2M—Alzheimer's disease	8.74e-06	0.000455	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—A2M—Alzheimer's disease	8.66e-06	0.000451	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.72e-06	0.000403	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.6e-06	0.000396	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	7.54e-06	0.000393	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.51e-06	0.000392	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	7.45e-06	0.000388	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.12e-06	0.000371	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.12e-06	0.000371	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	7.06e-06	0.000368	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	7.06e-06	0.000368	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	6.93e-06	0.000361	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.62e-06	0.000345	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	6.56e-06	0.000342	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.25e-06	0.000326	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.19e-06	0.000323	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.08e-06	0.000317	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.06e-06	0.000316	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	6e-06	0.000313	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.22e-06	0.000272	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.2e-06	0.000271	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.18e-06	0.00027	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.15e-06	0.000268	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.75e-06	0.000248	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.71e-06	0.000246	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.28e-06	0.000223	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.24e-06	0.000221	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4e-06	0.000208	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.98e-06	0.000208	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.96e-06	0.000207	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.95e-06	0.000206	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.95e-06	0.000206	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.91e-06	0.000204	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.47e-06	0.000181	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.44e-06	0.000179	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—INS—Alzheimer's disease	3.4e-06	0.000177	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—INS—Alzheimer's disease	3.37e-06	0.000176	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.98e-06	0.000156	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.96e-06	0.000154	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.73e-06	0.000142	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.71e-06	0.000141	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.37e-06	7.15e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.36e-06	7.09e-05	CbGpPWpGaD
